# Advances in extrusion-based bioprinting enabled by advanced printhead and nozzle designs

**Authors:** Jianfeng Li, Peer Fischer

PMC · DOI: 10.1016/j.mtbio.2026.102941 · Materials Today Bio · 2026-02-16

## TL;DR

This paper reviews advances in extrusion-based bioprinting, focusing on new printhead and nozzle designs that could improve biomedical applications.

## Contribution

The paper provides a comprehensive review of printhead designs and proposes directions for next-generation development in bioprinting.

## Key findings

- Extrusion-based bioprinting is constrained by material viscoelasticity and spatial resolution.
- Recent technological breakthroughs in printhead design are highlighted.
- Persistent bottlenecks include trade-offs between printing speed and cell viability.

## Abstract

3D printing is a rapidly evolving technology that enables new applications in biomedical engineering. In particular, its role in the fabrication of complex living tissues and multimaterial structures that support living cells opens new possibilities for biomaterial processing as well as potential clinical applications. Among the various 3D printing modalities developed over recent decades, extrusion-based printing shows particular promise for bioprinting and a number of successful examples are highlighted in this review. However, despite its widespread adoption, extrusion-based 3D printing is constrained by the limited range of viscoelasticities that can be processed, certain inefficiencies in multi-material printing, restricted spatial resolution and fundamental trade-offs between printing speed and cell viability in bioprinting applications. Here, we present a comprehensive review of existing printhead designs for extrusion-based 3D printing, with a specific focus on biomedical applications. We highlight recent technological breakthroughs, identify persistent bottlenecks and propose strategic directions for next-generation printhead development aimed at overcoming current limitations. Our goal is to catalyze innovation in printhead engineering for biomedical applications to enable the fabrication of structures that are still unattainable with current extrusion-based 3D printing systems.

Image 1

## Full-text entities

- **Genes:** PHF1 (PHD finger protein 1) [NCBI Gene 5252] {aka MTF2L2, PCL1, TDRD19C, hPHF1}
- **Diseases:** hyperthermia (MESH:D005334), inflammatory (MESH:D007249), kidney (MESH:D007674), cytotoxicity (MESH:D064420), bone defects (MESH:D001847)
- **Chemicals:** water (MESH:D014867), PMMA (MESH:D019904), iron (MESH:D007501), Iron oxide (MESH:C000499), metal (MESH:D008670), oxygen (MESH:D010100), polymer (MESH:D011108), Calcein (MESH:C007740), MXene (MESH:C000723374), CNC (-), polycaprolactone (MESH:C016240)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936692/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936692/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936692/full.md

---
Source: https://tomesphere.com/paper/PMC12936692